| 영문 | male reproductive system | 한글 | 남성생식기계 |
|---|---|---|---|
| 설명 | 남성의 생식기는 여러 기관으로 구성되어 있다. 고환, 부고환, 정관, 정낭, 전립샘, 외부성기(음경) 등으로 구성되는데, 실제적으로 정자를 생성하는 곳은 단 한 곳 고환뿐이며, 나머지 기관은 이를 돕는 기능을 수행하고 있다. 정자는 고환의 정세관이란 곳에서 만들어진 뒤에 밖으로 나와 긴 여정을 시작하게 된다. 그 뒤 부고환을 지나 좀 더 성숙해 진 뒤에 정관에서 정낭의 분비물과 만나고 다시 요도로 나가게 된다. 이때 요도 뒤쪽에 위치하는 전립샘의 분비물이 합쳐지게 되고 이 정액은 외부성기를 거쳐서 밖으로 나가게 된다.  |
||
| 영문 | reproductive system | 한글 | 생식기계통 |
|---|---|---|---|
| 설명 | 1.남성생식계통: 남성생식기는 정자(sperm)를 생성하는 고환과 정자의 성숙, 운반, 그리고 사정에 관여하는 부고환, 정관, 음경(penis) 등으로 이루어져 있으며, 부속기관으로 외분비샘인 정낭(seminal vesicle), 전립샘(prostate), 요도망물샘(bulbourethral gland, Cowper’s gland) 등을 갖추고 있다. 고환은 정자를 생산하는 생식샘인 동시에 남성호르몬(testosterone)을 분비하는 내분비샘이다. 고환에서 분비되는 남성호르몬은 정자생성과 생식기의 발달 및 유지에 필수적인 역할을 하므로 남성생식기능의 원천은 고환에 있다고 볼 수 있다. 2.여성생식계통: 여성생식기는 난자를 생성하는 난소와 난자를 자궁으로 운반하는 난관, 그리고 자궁과 질로 이루어져 있으며 외분비선인 바르톨린샘를 갖추고 있다. 난소는 난자를 생성하는 생식샘인 동시에 여성호르몬을 분비케하는 내분비샘이다. 월경주기 전반부에 난자를 생성시키기위해 성숙되고 있는 난포에서 분비되는 에스트로겐은 여성 2차 성징의 발달을 관장할 뿐 아니라 자궁내막을 장차 수정될 수정란이 착상하기에 알맞은 상태로 만들어준다. 난자가 분비되고 남은 황체에서 분비되는 푸로게스테론은 자궁내막을 붓도록 하면 분비액을 증가시키며 자궁근의 수축을 방해하여 임신시 임신을 지속시키는 역할을 한다. |
||
| ART | absolute retention time; Accredited Record Technician; acoustic reflex test; algebraic reconstructio... |
|---|---|
| CAD | cadaver, cadaveric; cold agglutinin disease; compressed air disease; computer-assisted design; compu... |
| CAR | Canadian Association of Radiologists; cancer-associated retinopathy; cardiac ambulation routine; cel... |
| VATS | Video Assisted Thoracoscopic Surgery, Video-assisted thoracic surgery |
| DART | developmental and reproductive toxicology |
| ART | Assisted Reproductive Technology |
|---|---|
| ART | Assisted Reproductive Techniques |
| ART | Assisted Reproductive Technologies |
| ARTs | Assisted Reproductive Technologies |
| ART | assisted reproduction technology |
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
|---|
| basic reproductive rate, ratio | <epidemiology> See Reproductive Ratio. (05 Dec 1998) |
|---|---|
| cells, reproductive | The eggs and sperm are the reproductive cells. Each mature reproductive cell is haploid in that it has a single set of 23 chromosomes. (12 Dec 1998) |
| reproductive | Relating to reproduction. (05 Mar 2000) |
| reproductive adaptation | A peculiarity of the reproductive mechanism of a species that results in it being better fitted to its environment (for example, prolonged seed dormancy). (09 Oct 1997) |
| reproductive and urinary physiology | Physiology of the human and animal body, male or female, in the reproductive process and the physiology of the urinary tract. (12 Dec 1998) |
| reproductive assimilation | In sensorimotor theory, an active cognitive process by which past experience is applied to novel situations. (05 Mar 2000) |
| reproductive cells | The eggs and sperm are the reproductive cells. Each mature reproductive cell is haploid in that it has a single set of 23 chromosomes. (12 Dec 1998) |
| reproductive control agents | Substances used either in the prevention or facilitation of pregnancy. (12 Dec 1998) |
| reproductive cycle | The cycle which begins with conception and extends through gestation and parturition. (05 Mar 2000) |
| reproductive endocrinologist | An ob-gyn who specialises in the treatment of hormonal disorders that affect reproductive function. (09 Oct 1997) |
| reproductive history | An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage. (12 Dec 1998) |
| reproductive medicine | A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intra-fallopian transfer of zygotes. (12 Dec 1998) |
| reproductive nucleus | <cell biology> The smaller nucleus in ciliate protozoans, fully active in inheritance and passed after meiosis to conjugating pairs. Gives rise to the macronucleus or macronuclei. Genes in the micronucleus are not actively transcribed. (18 Nov 1997) |
| reproductive ratio | <epidemiology> 1. Basic reproductive ratio , Ro , a dimensionless parameter which encapsulates the biological details of different transmission mechanisms. For microparasites, Ro , is defined as the average number of secondary cases of infection to which one primary case gives rise throughout its infectious period if introduced into a defined population consisting solely of susceptible individuals. For macroparasites, Ro , is the average number of female offspring (or just offspring in the case of hermaphroditic species) produced throughout the lifetime of a mature female parasite, which themselves achieve reproductive maturity in the absence of density-dependent constraints on the parasite establishment, survival or reproduction. Also known as the basic reproduction rate, number. 2. Effective reproductive ratio , R , The number of secondary cases (microparasites) or female offspring (macroparasites) produced in a host population not consisting entirely of susceptible individuals (microparasites) or within which density dependent constraints limit parasite population growth (macroparasites). Under conditions of stable endemic infection, R=1. (05 Dec 1998) |
| reproductive surgeon | An ob-gyn or urologist who specialises in the surgical correction of anatomical disorders that impair reproductive function. (09 Oct 1997) |
| assisted reproductive technology |
(ART) any procedure that involves the manipulation of eggs or sperm, such as in vitro fertilization and gamete intrafallopian transfer, used to establish pregnancy in the treatment of infertility.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| assisted reproductive technology |
Procedures involving retrieval of eggs, and the enhancement of eggs and sperm outside the body. It includes procedures such as gamete intrafallopian transfer (GIFT), in vitro fertilization (IVF), and zygote intrafallopian transfer/tubal embryo transfer (ZIFT/TET).
출처: www.haveababy.com/learn/glossary.asp
|
| assisted reproductive technology |
advanced procedures used to assist in achieving pregnancy. Includes procedures such a as IVF, GIFT, and ZIFT.
출처: uuhsc.utah.edu/andrology/education_5.html
|
| assisted reproductive technology |
medical procedures, such as intrauterine insemination, that are performed to help infertile couples conceive.
출처: www.holyname.org/health_information_resources/heal...
|
| assisted reproductive technology |
All treatments or procedures that include the in vitro handling of human oocytes and sperm or embryos for the purpose of establishing a pregnancy. ART does not include artificial (intrauterine) insemination.
출처: www.fda.gov/ohrms/dockets/ac/03/briefing/3985B1_03...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|